A Retrospective study In Children who have switched to Isosource Junior Mix formula (RICIMIX study) will review paediatric children > 12 months of age who require Isosource Junior Mix as an enteral tube feeding formula and have consumed the formula for at least 1 month. The purpose of this study is to understand If there has been an improvement in outcomes/ experiences

• The current usage of ISJMIX formula in children who require blended diets
• Improved feeding intolerances
• Improved patient outcomes/ experiences

Retrospective data will be collected using questionnaire by the dietitians at the nutrition and dietetic department. All completed questionnaires will be sent back to Nestle Health Science/ CRO company.

The primary objectives:

The following measures will be collected retrospectively after 1 month use of ISJMIX

• Feeding tolerance [no change, tolerance improved, tolerance worsened]: gastric residuals, gagging/retching, vomiting, abdominal distention/ gas, stool consistency issues (too hard, too loose)
• Volume of formula consumed in a day

The secondary objective is to collect restropective data on:

• Any improved patient outcomes noted
• Calculate the potential cost savings made when using ISJMIX to help manage the feeding intolerances
• Calculate the potential costs benefit of using ISJMIX over other standard formulas

Inclusion Criteria:

• All children who are using Isosource Junior Mix as tube feed formula

Exclusion Criteria:

• All children who did not switch to Isosource Junior Mix feed formula

Paediatric children > 12 months of age who require Isosource Junior Mix as an enteral tube feeding formula and have consumed the formula for at least 1 month